InVitro Capital
Arlen Meyers, MD, MBA, serves as a Professor Emeritus of Otolaryngology at the University of Colorado School of Medicine since June 1976. Currently, Arlen holds multiple advisory roles, including Strategic Advisor at MedTech Syndicates, Jesica.ai, InVitro Capital, and PertexaHealthTech, as well as Editor in Chief at PhysicianX and WebMD's Medscape Otolaryngology-Facial Plastic Surgery. Arlen's focus is on enhancing healthcare through artificial intelligence, with significant contributions to MI10 as Partner and Strategic Advisor. Education includes an MD from Jefferson Health, an MBA from the University of Colorado Denver, and a range of fellowships from esteemed institutions. Arlen is also a Faculty Lecturer at the Kansas Health Sciences Center, teaching innovation and entrepreneurship.
This person is not in any teams
InVitro Capital
2 followers
At the heart of the AI revolution, InVitro Capital emerges as a pioneering Venture Studio, committed to transforming the landscape for small and medium-sized businesses ("SMBs"). Inspired by "In Vitro", the scientific method's ability to nurture life under controlled conditions, we specialize in de-risking the startup building process, bringing visionary ideas to life with precision and foresight. Our mission is clear: to unleash the full potential of autonomous AI on Software-as-a-Service ("SaaS") solutions, propelling businesses to new heights of productivity and market competitiveness. We're not merely participants in this technological transformation; we're leading the charge, navigating the uncharted potential of the SMB sector. Our portfolio companies ("PortCos") span critical sectors such as HealthTech, FinTech, AdTech, and HR. This diverse ecosystem reflects our dedication to enriching the SMB landscape with cutting-edge AI solutions, reshaping industries and setting new standards of excellence.